Finished
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
NCT01358097 · Icahn School of Medicine at Mount Sinai · Updated 10 April 2014
- What is being tested
- Not stated
- For
- Head and Neck Cancer; Oropharyngeal Cancer; Human Papillomavirus; Squamous Cell Cancer
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 33 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started Oct 2010, ends Sept 2013. Registered 23 May 2011.
- Results
- None posted yet.
In the researchers' words
The purpose of this study is to investigate the role of the immune system in the response of squamous cell cancers of the head and neck to treatment that includes radiation therapy. Current research demonstrates that several natural immune cells and molecules affect the way the body's immune system interacts with a cancerous growth. Some cancers may be related to infection with a virus, such as the Human Papilloma Virus (HPV). Studying the activity of the immune system in head and neck cancers, especially cancers related to HPV infections, can provide valuable information to better understand the body's interaction with cancer cells.
Sites
- Icahn School of Medicine at Mount Sinai, Otolaryngology - Head and Neck SurgeryNew York, New York, United States